SCHEMBL26623559

SCHEMBL26623559

C/C(=C\C(=O)O)c1cnc2ccc(Br)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 2/20 0.41
MGAM O43451 1/20 0.41
MALT1 Q9UDY8 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
TSHR P16473 1/20 0.38
NR4A1 P22736 1/20 0.37
NR4A2 P43354 1/20 0.37
NR4A3 Q92570 1/20 0.37
F2 P00734 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
TBXAS1 P24557 2/20 0.36
GPR183 P32249 1/20 0.36
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14003 0.85 MALT1 (0.44) ALPLMGAMMALT1ALDH1A1HTT
SCHEMBL9388 0.85 MALT1 (0.44) ALPLMGAMMALT1ALDH1A1HTT
SCHEMBL9389 0.85 MALT1 (0.44) ALPLMGAMMALT1ALDH1A1HTT
SCHEMBL26750777 0.82 ALPL (0.39) ALPLMGAMMALT1ALDH1A1HTT
SCHEMBL30628954 0.82 ALPL (0.39) ALPLMGAMMALT1ALDH1A1HTT
SCHEMBL9637 0.82 HTT (0.46) ALPLMGAMMALT1ALDH1A1HTT
SCHEMBL3095833 0.81 MGAM (0.64) MGAMRAB9ANPC1CYP1A2CYP3A4
SCHEMBL3095823 0.81 MGAM (0.64) MGAMRAB9ANPC1CYP1A2CYP3A4
SCHEMBL3095816 0.81 MGAM (0.64) MGAMRAB9ANPC1CYP1A2CYP3A4
SCHEMBL9508 0.81 MGAM (0.62) ALPLMGAMMALT1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240191211-A1 BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING PROMEGA CORPORATION 2024-06-13 US disclosed
WO-2023215497-A1 PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF PROMEGA CORPORATION (US) 2023-11-09 WO disclosed
WO-2023215514-A2 BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING PROMEGA CORPORATION (US) 2023-11-09 WO disclosed
US-20230357266-A1 PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF PROMEGA CORPORATION 2023-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357266-A1 PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF BTD, HLCS, TYR ALPL 1590/4885MGAM 4347/4885MALT1 3463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.